The role of baseline N-terminal B-type natriuretic peptide in the early postoperative period in patients with infective endocarditis
PDF (Українська)

Keywords

heart failure markers
troponin
procalcitonin
cardiac surgery
sepsis

How to Cite

Koltunova, H., & Chyzh, K. (2024). The role of baseline N-terminal B-type natriuretic peptide in the early postoperative period in patients with infective endocarditis. Experimental and Clinical Medicine, 93(4). https://doi.org/10.35339/ekm.2024.93.4.kch

Abstract

In press

Biomarkers indicating various pathophysiological stages of Acute Heart Failure (AHF) remain crucial as a powerful tool for diagnosing and stratifying high-risk patients susceptible to heart failure progression. Although early cardiac surgical intervention is a primary treatment approach for AHF in Infective Endocarditis (IE), hospital mortality rates remain high. This single-center retrospective cohort study included clinical data of patients with active IE who underwent cardiac surgery at the Amosov National Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine from 2019 to 2021. The diagnosis of IE was established according to the Duke criteria. All patients underwent surgery under moderate hypothermia (30°C) with the use of a crystalloid cardioplegic solution. Data on preoperative heart function, serum creatinine, hemoglobin, procalcitonin, troponin, and NT-pro-BNP were collected. Patients were grouped according to the degree of preoperative heart failure based on the New York Heart Association Functional Classification, and NT-proBNP cutoff values were determined for each group. Predictors of AHF were analyzed, and clinical outcomes in patients with IE were assessed and compared. In the early postoperative period, the duration of dobutamine and norepinephrine therapy, mechanical ventilation, and length of stay in the Intensive Care Unit (ICU) were evaluated. Patients with higher NT-pro-BNP levels exhibited signs of acute heart failure (end-diastolic index (p<0.05), end-systolic index (p<0.001)) and were characterized by acute kidney injury (serum creatinine (p<0.01)) and anemia (erythrocytes (p<0.01)). No statistical difference in procalcitonin and troponin levels was observed between the groups. A significant positive correlation was found between baseline NT-proBNP level and the duration of dobutamine infusion (r2=0.156; p<0.001), norepinephrine infusion (r2=0.224; p=0.019), mechanical ventilation (r2=0.073; p=0.006), and ICU stay (r2=0.086; p=0.004).

Keywords: heart failure markers, troponin, procalcitonin, cardiac surgery, sepsis.

https://doi.org/10.35339/ekm.2024.93.4.kch
PDF (Українська)

References

Diab M, Lehmann T, Bothe W, Akhyari P, Platzer S, Wendt D, et al.; REMOVE Trial Investigators. Cytokine Hemoadsorption During Cardiac Surgery Versus Standard Surgical Care for Infective Endocarditis (REMOVE): Results from a Multicenter Randomized Controlled Trial. Circulation. 2022;145(13):959-968. DOI: 10.1161/CIRCULATIONAHA.121.056940. PMID: 35213213.

Carino D, Fernandez-Cisneros A, Hernandez-Meneses M, Sandoval E, Llopis J, Falces C, et al.; Grup d'Estudi d'Endocarditis Infecciosa de l'Hospital Clínic de Barcelona [Infective Endocarditis Study Group of the Hospital Clínic de Barcelona]. The fate of active left-side infective endocarditis with operative indication in absence of valve surgery. J Card Surg. 2020;35(11):3034-40. DOI: 10.1111/jocs.14967. PMID: 32827161.

Van Hemelrijck M, Sromicki J, Frank M, Greutmann M, Ledergerber B, Epprecht J, et al. Dismal prognosis of patients with operative indication without surgical intervention in active left-sided infective endocarditis. Front Cardiovasc Med. 2023;10:1223878. DOI: 10.3389/fcvm.2023.1223878. PMID: 37692048.

Hermanns H, Eberl S, Terwindt LE, Mastenbroek TCB, Bauer WO, van der Vaart TW, Preckel B. Anesthesia Considerations in Infective Endocarditis. Anesthesiology. 2022;136(4):633-56. DOI: 10.1097/ALN.0000000000004130. PMID: 35120196.

Wei XB, Liu YH, He PC, Yu DQ, Zhou YL, Tan N, Chen JY. Prognostic value of N-terminal prohormone brain natriuretic peptide for in-hospital and long-term outcomes in patients with infective endocarditis. Eur J Prev Cardiol. 2017;24(7):676-84. DOI: 10.1177/2047487316686436. PMID: 28067531.

Kahveci G, Bayrak F, Mutlu B, Bitigen A, Karaahmet T, Sonmez K, et al. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endocarditis. Am J Cardiol. 2007;99(10):1429-33. DOI: 10.1016/j.amjcard.2006.12.071. PMID: 17493474.

Shiue AB, Stancoven AB, Purcell JB, Pinkston K, Wang A, Khera A, et al. Relation of level of B-type natriuretic peptide with outcomes in patients with infective endocarditis. Am J Cardiol. 2010;106(7):1011-5. DOI: 10.1016/j.amjcard.2010.05.034. PMID: 20854966.

Siciliano RF, Gualandro DM, Mueller C, Seguro LF, Goldstein PG, Strabelli TM, et al. Incremental value of B-type natriuretic peptide for early risk prediction of infective endocarditis. Int J Infect Dis. 2014;29:120-4. DOI: 10.1016/j.ijid.2014.08.017. PMID: 25461241.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.